Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1M Sell
11,100
-208
-2% -$331K 0.48% 46
2026
Q1
$14.9M Sell
11,308
-388
-3% -$532K 0.41% 52
2025
Q4
$12.5M Sell
11,696
-2,775
-19% -$2.89M 0.3% 64
2025
Q3
$14M Sell
14,471
-1,705
-11% -$1.34M 0.35% 58
2025
Q2
$13M Sell
16,176
-1,541
-9% -$1.11M 0.35% 61
2025
Q1
$11.7M Buy
+17,717
New +$12.9M 0.36% 64

Other funds holding ASML

Grimes & Company's ASML Position: Q2 2026 in Review

Grimes & Company reduced its ASML (ASML) stake by 1.8% in Q2 2026, selling an estimated $331K and leaving 11,100 shares worth $22.1M. The position accounts for 0.48% of the portfolio, ranked #46.

Grimes & Company first reported a position in ASML in Q1 2025 and has held it in 6 quarters since. 1,065 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Grimes & Company held 11,100 shares of ASML worth $22.1M as of Q2 2026.
  • Grimes & Company sold 208 ASML shares in Q2 2026, an estimated $331K.
  • ASML made up 0.48% of Grimes & Company's portfolio in Q2 2026, its #46 holding.
  • Grimes & Company first reported a position in ASML in Q1 2025 and has held it in 6 quarters since.
  • 1,065 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.